Literature DB >> 34493831

Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk.

Samuel K Powell1,2,3,4,5,6, Callan O'Shea1,2,3,4,6, Kayla Townsley1,2,3,4,5, Iya Prytkova1,2,5, Kristina Dobrindt1,2,3,4,6, Rahat Elahi1,2,3,4, Marina Iskhakova1,2,3, Tova Lambert1,2,3, Aditi Valada1,2,3, Will Liao7, Seok-Man Ho1,2,3,4, Paul A Slesinger2, Laura M Huckins1,3, Schahram Akbarian8,9,10, Kristen J Brennand11,12,13,14,15.   

Abstract

Dopaminergic neurons are critical to movement, mood, addiction, and stress. Current techniques for generating dopaminergic neurons from human induced pluripotent stem cells (hiPSCs) yield heterogenous cell populations with variable purity and inconsistent reproducibility between donors, hiPSC clones, and experiments. Here, we report the rapid (5 weeks) and efficient (~90%) induction of induced dopaminergic neurons (iDANs) through transient overexpression of lineage-promoting transcription factors combined with stringent selection across five donors. We observe maturation-dependent increase in dopamine synthesis and electrophysiological properties consistent with midbrain dopaminergic neuron identity, such as slow-rising after- hyperpolarization potentials, an action potential duration of ~3 ms, tonic sub-threshold oscillatory activity, and spontaneous burst firing at a frequency of ~1.0-1.75 Hz. Transcriptome analysis reveals robust expression of genes involved in fetal midbrain dopaminergic neuron identity. Specifically expressed genes in iDANs, as well as those from isogenic induced GABAergic and glutamatergic neurons, were enriched in loci conferring heritability for cannabis use disorder, schizophrenia, and bipolar disorder; however, each neuronal subtype demonstrated subtype-specific heritability enrichments in biologically relevant pathways, and iDANs alone were uniquely enriched in autism spectrum disorder risk loci. Therefore, iDANs provide a critical tool for modeling midbrain dopaminergic neuron development and dysfunction in psychiatric disease.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2021        PMID: 34493831      PMCID: PMC8898985          DOI: 10.1038/s41380-021-01273-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  92 in total

Review 1.  The action potential in mammalian central neurons.

Authors:  Bruce P Bean
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

Review 2.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

3.  Gene Ontology Semantic Similarity Analysis Using GOSemSim.

Authors:  Guangchuang Yu
Journal:  Methods Mol Biol       Date:  2020

Review 4.  Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.

Authors:  S K Powell; J Gregory; S Akbarian; K J Brennand
Journal:  Mol Cell Neurosci       Date:  2017-05-23       Impact factor: 4.314

5.  Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Authors:  Maria Sundberg; Helle Bogetofte; Tristan Lawson; Johan Jansson; Gaynor Smith; Arnar Astradsson; Michele Moore; Teresia Osborn; Oliver Cooper; Roger Spealman; Penelope Hallett; Ole Isacson
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

Review 6.  The role of dopamine in the brain - lessons learned from Parkinson's disease.

Authors:  David Meder; Damian Marc Herz; James Benedict Rowe; Stéphane Lehéricy; Hartwig Roman Siebner
Journal:  Neuroimage       Date:  2018-11-20       Impact factor: 6.556

Review 7.  Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells.

Authors:  Elizabeth A LaMarca; Samuel K Powell; Schahram Akbarian; Kristen J Brennand
Journal:  Front Pediatr       Date:  2018-04-03       Impact factor: 3.418

8.  A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons.

Authors:  Sergio Espeso-Gil; Tobias Halene; Jaroslav Bendl; Bibi Kassim; Gabriella Ben Hutta; Marina Iskhakova; Neda Shokrian; Pavan Auluck; Behnam Javidfar; Prashanth Rajarajan; Sandhya Chandrasekaran; Cyril J Peter; Alanna Cote; Rebecca Birnbaum; Will Liao; Tyler Borrman; Jennifer Wiseman; Aaron Bell; Michael J Bannon; Panagiotis Roussos; John F Crary; Zhiping Weng; Stefano Marenco; Barbara Lipska; Nadejda M Tsankova; Laura Huckins; Yan Jiang; Schahram Akbarian
Journal:  Genome Med       Date:  2020-02-19       Impact factor: 11.117

9.  Homogenous generation of dopaminergic neurons from multiple hiPSC lines by transient expression of transcription factors.

Authors:  Sameehan Mahajani; Anupam Raina; Claudia Fokken; Sebastian Kügler; Mathias Bähr
Journal:  Cell Death Dis       Date:  2019-11-27       Impact factor: 8.469

10.  ASCL1- and DLX2-induced GABAergic neurons from hiPSC-derived NPCs.

Authors:  Natalie Barretto; Hanwen Zhang; Samuel K Powell; Michael B Fernando; Siwei Zhang; Erin K Flaherty; Seok-Man Ho; Paul A Slesinger; Jubao Duan; Kristen J Brennand
Journal:  J Neurosci Methods       Date:  2020-02-14       Impact factor: 2.390

View more
  4 in total

Review 1.  The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System.

Authors:  Marco Colizzi; Riccardo Bortoletto; Rosalia Costa; Sagnik Bhattacharyya; Matteo Balestrieri
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

2.  Mapping cis-regulatory elements in human neurons links psychiatric disease heritability and activity-regulated transcriptional programs.

Authors:  Carlos Sanchez-Priego; Ruiqi Hu; Linda L Boshans; Matthew Lalli; Justyna A Janas; Sarah E Williams; Zhiqiang Dong; Nan Yang
Journal:  Cell Rep       Date:  2022-05-31       Impact factor: 9.995

Review 3.  Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation.

Authors:  Amy J Hulme; Simon Maksour; Mitchell St-Clair Glover; Sara Miellet; Mirella Dottori
Journal:  Stem Cell Reports       Date:  2021-12-30       Impact factor: 7.765

4.  Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.

Authors:  Riccardo Bortoletto; Marco Colizzi
Journal:  Healthcare (Basel)       Date:  2022-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.